A 3D QSAR study on a set of dopamine D4 receptor antagonists

被引:44
|
作者
Boström, J
Böhm, M
Gundertofte, K
Klebe, G
机构
[1] H Lundbeck & Co AS, DK-2500 Copenhagen, Denmark
[2] Univ Marburg, Dept Pharmaceut Chem, D-35032 Marburg, Germany
关键词
D O I
10.1021/ci034004+
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
molecular alignments obtained from a previously reported pharmacophore model have been employed in a three-dimensional quantitative structure-activity relationship (3D QSAR) study, to obtain a more detailed insight into the structure-activity relationships for D-2 and D-4 receptor antagonists. The frequently applied CoMFA method and the related CoMSIA method were used. Statistically significant models have been derived with these two methods, based on a set of 32 structurally diverse D-2 and D-4 receptor antagonists. The CoMSIA and the CoMFA methods produced equally good models expressed in terms of q(2) values. The predictive power of the derived models were demonstrated to be high. Graphical interpretation of the results, provided by the CoMSIA method, brings to light important structural features of the compounds related to either low- or high-affinity D-2 or D-4 antagonism. The results of the 3D QSAR studies indicate that bulky N-substituents decrease D-2 binding, whereas D-4 binding is enhanced. Electrostatically favorable and unfavorable regions exclusive to D-2 receptor binding were identified. Likewise, certain hydrogen-bond acceptors can be used to lower D-2 affinity. These observations may be exploited for the design of novel dopamine D-4 selective antagonists.
引用
收藏
页码:1020 / 1027
页数:8
相关论文
共 50 条
  • [1] Dopamine D4 receptor antagonists
    Kulagowski, JJ
    Patel, S
    [J]. CURRENT PHARMACEUTICAL DESIGN, 1997, 3 (04) : 355 - 366
  • [2] Selective dopamine D4 receptor antagonists
    Sanner, MA
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 1998, 8 (04) : 383 - 393
  • [3] A 3D-pharmacophore model for dopamine D4 receptor antagonists
    Boström, J
    Gundertofte, K
    Liljefors, T
    [J]. MOLECULAR MODELING AND PREDICTION OF BIOACTIVITY, 2000, : 382 - 383
  • [4] The Universal 3D QSAR Model for Dopamine D2 Receptor Antagonists
    Zieba, Agata
    Zuk, Justyna
    Bartuzi, Damian
    Matosiuk, Dariusz
    Poso, Antti
    Kaczor, Agnieszka A.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (18)
  • [5] A pharmacophore model for dopamine D4 receptor antagonists
    Jonas Boström
    Klaus Gundertofte
    Tommy Liljefors
    [J]. Journal of Computer-Aided Molecular Design, 2000, 14 : 769 - 786
  • [6] A pharmacophore model for dopamine D4 receptor antagonists
    Boström, J
    Gundertofte, K
    Liljefors, T
    [J]. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2000, 14 (08) : 769 - 786
  • [7] Isoxazolylpyrrolidinylpiperazine Ligands, a New Class for Dopamine D3 and D4 Receptor Antagonists
    Oh, Yoo Na
    Kwak, Jumyung
    Koh, Hun Yeong
    Jung, Sun Ho
    [J]. BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 2012, 33 (12) : 4227 - 4230
  • [8] Discovery of dopamine D4 receptor antagonists with planar chirality
    Sanna, Fabrizio
    Ortner, Birgit
    Huebner, Harald
    Loeber, Stefan
    Tschammer, Nuska
    Gmeiner, Peter
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (07) : 1680 - 1684
  • [9] The discovery of potent and selective dopamine D4 receptor antagonists
    Faraci, WS
    Zorn, SH
    Sanner, MA
    Fliri, A
    [J]. CURRENT OPINION IN CHEMICAL BIOLOGY, 1998, 2 (04) : 535 - 540
  • [10] Return of D4 Dopamine Receptor Antagonists in Drug Discovery
    Lindsley, Craig W.
    Hopkins, Corey R.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (17) : 7233 - 7243